EUROpean Treatment & Reduction of Acute Coronary Syndrome cost analysis (EUROTRACS)

Henrique Barros

Principal Investigator

Integrated Member (PhD)

Type of project:

International

Reference:

20121207

Participating institutions:

PSMAR; HCC; DEASL; FMUP; HMGU; ESREFO; AEPMCV; ISS

Sources of financing:

Executive Agency for Health and Consumers

Start date:

01/06/2013

(Predicted) End date:

01/06/2015

Research line:

L1 - Life Course Research and Healthy Ageing L4 - Patient and Population Outcomes Research

Research lab:

Perinatal Determinants of Health Individual- and System-level Factors Towards the Attainment of High Value Health Care

Summary:

The present proposal’s main objective consists of utility analysis (cost-effectiveness) in terms of cost per Quality-Adjusted Life Year (QALY) saved in two fields:

 

1) three population interventions (and their combinations) designed to prevent coronary artery disease incidence aimed at reducing smoking, dyslipidaemia, and hypertension population prevalence, and

 

2) optimal use of coronary angiography and percutaneous intervention procedures in the management of patients with acute coronary syndrome (ACS) with special emphasis on the elderly (>64 years) to minimize the inequalities in this patient subgroup that has higher mortality than patients.

 

Click here to see EUROTRACS website

Research Team